Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma.
METHODS
The diffuse large cell non-Hodgkin lymphomas are a heterogeneous group of neoplasms that are potentially curable. To identify important predictors of clinical outcome, the authors evaluated the clinical and pathologic features of 114 patients with newly diagnosed diffuse large B-cell lymphoma who were uniformly staged and treated with curative intent. The authors were particularly interested in determining whether any pathologic features added to the ability of the clinical features to predict patient survival.


RESULTS
Several clinical and pathologic features were found to be associated with survival by univariate analysis. However, multivariate analysis disclosed that only the stage of disease and the symptom status were significantly associated with survival. Low stage and lack of B symptoms were favorable indicators of overall survival and failure-free survival.


CONCLUSIONS
The authors suggest that the evaluation of pathologic features in diffuse large B-cell lymphoma has little prognostic utility and recommend that the pathology evaluation be limited to features that are useful for diagnostic purposes.
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198.
H
H
Nakamine
R G
RG
Bagin
J M
JM
Vose
M A
MA
Bast
P J
PJ
Bierman
J O
JO
Armitage
D D
DD
Weisenburger
D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis
D015703:Antigens, CD